The Feasibility of Florbetapir Quantitation



Status:Completed
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:5/5/2014
Start Date:August 2013
End Date:January 2014
Contact:Avid Clinical Operations
Email:clinicaloperations@avidrp.com
Phone:215-298-0700

Use our guide to learn which trials are right for you!

The overall objective of the study is to assess the feasibility of implementing a
quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use
of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation.


Inclusion Criteria:

- Readers have undergone Amyvid reader training

- Readers have minimal experience with quantitation of amyloid PET scans

Exclusion Criteria:

- Readers have previously been trained to quantitate amyloid PET scans
We found this trial at
1
site
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials